Your provider will determine if and when these tests are necessary
Factors like dosage, underlying health conditions, and lifestyle habits can all impact how quickly you lose weight (or control blood sugar) on tirzepatide
Ding X, Bian N, Wang J, Chang X, An Y, Wang G, et al
Screening for personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 is essential, as tirzepatide is contraindicated in these conditions
Starting January 1, 2026, these medications will no longer be covered for weight loss or weight loss-related indications: Ozempic Rybelsus Mounjaro Victoza Byeta Bydureon Trulicity Ensuring Continuation of Therapy If you are currently prescribed any GLP-1 medication for an approved indication, it is important to ensure your prescriber includes the appropriate diagnosis code (ICD-10) when submitting your prescription